MedTrace Logo

Pneumoproteins Expression in the Organ Donor

NCT02032069 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2016-03-15

No results posted yet for this study

Summary

Primary graft dysfunction, a form of reperfusion pulmonary edema that occurs early after lung transplantation, shares key clinical and pathological features with acute lung injury and its more severe form, the acute respiratory distress syndrome. However, in contrast to acute lung injury/acute respiratory distress syndrome, in which biomarkers in plasma, urine and lung edema fluid have prognostic and pathogenetic value, the role of biomarkers in primary graft dysfunction has been less thoroughly explored. We will try in this study de determine the rule of pneumoproteins in the donor organ on the pulmonary edema in the recipient.

Conditions

  • Primary Graft Dysfunction

Interventions

OTHER

no intervention

Sponsors & Collaborators

  • University Hospital of Mont-Godinne

    lead OTHER

Eligibility

Min Age
5 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02032069 on ClinicalTrials.gov